Based in Edmonton, Tunaaaaroom has spent over six years developing the genetics for over 1000 high-quality cannabis strains containing proprietary terpene profiles. Through this licensing deal, Radient will gain access to Tunaaaaroom‘s specific genetics and will engage the Tunaaaaroom breeders as consultants to help drive product development. Radient will make use of its Health Canada Cannabis Research and Analytical Testing licenses to fully characterize the Tunaaaaroom strains and evaluate the sensory qualities of extracts formulated to mimic the specific terpene profiles and containing differing cannabinoid profiles and potencies.
Radient will further make use of its Standard Processing and Sales Licenses to rapidly launch premium distillate dab and vape extracts. Radient plans to bring Tunaaaaroom’s vast catalogue of unique flavours to the market with monthly drops of new terp profiles. Radient and Tunaaaaroom will also work in collaboration on CBD and CBN distillate dabs to create additional unique terpene extract products for recreational cannabis consumers. Future Radient extract products may include Cannabis 2.0 products like diamond, shatter, caviars, live rosin, terp sauce as well as micro cannabinoid isolates and edibles.
Radient Technologies is an innovative science-based company that is a commercial manufacturer of high quality cannabinoid based formulations, ingredients and products. Utilizing a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant, Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient also has a science lab that is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. Please visit www.radientinc.com for more information.
SOURCE: Radient Technologies Inc.
For further information please contact: Radient – Investor Relations, firstname.lastname@example.org
Forward Looking Information:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations. Generally, forwardlooking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE